Literature DB >> 3553952

Generic drug substitution revisited.

B L Strom.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3553952     DOI: 10.1056/NEJM198706043162306

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Bioinequivalence and drug toxicity. How great is the problem and what can be done?

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

2.  Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.

Authors:  C Bourgault; E Elstein; J Le Lorier; S Suissa
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

Review 3.  Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Alexander S Misono; Joy L Lee; Margaret R Stedman; M Alan Brookhart; Niteesh K Choudhry; William H Shrank
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

4.  Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.

Authors:  Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 5.  Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Margaret R Stedman; Ellen J Bubrick; Joshua J Gagne; Alexander S Misono; Joy L Lee; M Alan Brookhart; Jerry Avorn; William H Shrank
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

6.  Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan.

Authors:  Chih-Wei Hsu; Sheng-Yu Lee; Yao-Hsu Yang; Liang-Jen Wang
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-10       Impact factor: 5.176

7.  Transplant coordinators' perceived impact of availability of multiple generic immunosuppression therapies on patients, workload, and posttransplant maintenance therapy.

Authors:  K Parker; E A Zagadailov; A S Bruno; A M Wiland
Journal:  J Transplant       Date:  2013-01-08

Review 8.  The use of GA-RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations-based model) method to optimize bioequivalence studies.

Authors:  Ezequiel Omar Nuske; Mikhail Morozov; Héctor Alejandro Serra
Journal:  Pharmacol Res Perspect       Date:  2021-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.